| http://www.w3.org/ns/prov#value | - This is a safety study, and once that continues, hopefully there will be good efficacy.While many scientists and physicians are hailing the trial as a landmark, others have expressed some nervousness.There is a lot of angst around these trials, Evan Y. Snyder, director of the stem cell program at the Sanford-Burnham Medical Research Institute in San Diego, told the Washington Post.
|
